These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2699404)

  • 21. Heterogeneity of mutations in maple syrup urine disease (MSUD): screening and identification of affected E1 alpha and E1 beta subunits of the branched-chain alpha-keto-acid dehydrogenase multienzyme complex.
    Nobukuni Y; Mitsubuchi H; Hayashida Y; Ohta K; Indo Y; Ichiba Y; Endo F; Matsuda I
    Biochim Biophys Acta; 1993 Nov; 1225(1):64-70. PubMed ID: 8161368
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.
    Mitsubuchi H; Nobukuni Y; Akaboshi I; Indo Y; Endo F; Matsuda I
    J Clin Invest; 1991 Apr; 87(4):1207-11. PubMed ID: 2010537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and biochemical basis of intermediate maple syrup urine disease. Occurrence of homozygous G245R and F364C mutations at the E1 alpha locus of Hispanic-Mexican patients.
    Chuang JL; Davie JR; Chinsky JM; Wynn RM; Cox RP; Chuang DT
    J Clin Invest; 1995 Mar; 95(3):954-63. PubMed ID: 7883996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular heterogeneity for bovine maple syrup urine disease.
    Healy PJ; Dennis JA
    Anim Genet; 1994 Oct; 25(5):329-32. PubMed ID: 7818167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease.
    Zhang B; Edenberg HJ; Crabb DW; Harris RA
    J Clin Invest; 1989 Apr; 83(4):1425-9. PubMed ID: 2703538
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A distinct variant of intermediate maple syrup urine disease.
    Gonzalez-Rios MC; Chuang DT; Cox RP; Schmidt K; Knopf K; Packman S
    Clin Genet; 1985 Feb; 27(2):153-9. PubMed ID: 3978850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.
    Danner DJ; Armstrong N; Heffelfinger SC; Sewell ET; Priest JH; Elsas LJ
    J Clin Invest; 1985 Mar; 75(3):858-60. PubMed ID: 3980729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. cDNA cloning of the E1 alpha subunit of the branched-chain alpha-keto acid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease.
    Zhang B; Kuntz MJ; Goodwin GW; Edenberg HJ; Crabb DW; Harris RA
    Ann N Y Acad Sci; 1989; 573():130-6. PubMed ID: 2634344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene analysis of Mennonite maple syrup urine disease kindred using primer-specified restriction map modification.
    Mitsubuchi H; Matsuda I; Nobukuni Y; Heidenreich R; Indo Y; Endo F; Mallee J; Segal S
    J Inherit Metab Dis; 1992; 15(2):181-7. PubMed ID: 1356170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complementation analysis in lymphoid cells from five patients with different forms of maple syrup urine disease.
    Jinno Y; Akaboshi I; Matsuda I
    Hum Genet; 1984; 68(1):54-6. PubMed ID: 6500555
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex.
    Chuang JL; Fisher CR; Cox RP; Chuang DT
    Am J Hum Genet; 1994 Aug; 55(2):297-304. PubMed ID: 8037208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A T-to-A substitution in the E1 alpha subunit gene of the branched-chain alpha-ketoacid dehydrogenase complex in two cell lines derived from Menonite maple syrup urine disease patients.
    Matsuda I; Nobukuni Y; Mitsubuchi H; Indo Y; Endo F; Asaka J; Harada A
    Biochem Biophys Res Commun; 1990 Oct; 172(2):646-51. PubMed ID: 2241958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Premature translation termination of the pre-E1 alpha subunit of the branched chain alpha-ketoacid dehydrogenase as a cause of maple syrup urine disease in Polled Hereford calves.
    Zhang B; Healy PJ; Zhao Y; Crabb DW; Harris RA
    J Biol Chem; 1990 Feb; 265(5):2425-7. PubMed ID: 2303405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deficiency of the E1 beta subunit in the branched-chain alpha-keto acid dehydrogenase complex due to a single base substitution of the intron 5, resulting in two alternatively spliced mRNAs in a patient with maple syrup urine disease.
    Hayashida Y; Mitsubuchi H; Indo Y; Ohta K; Endo F; Wada Y; Matsuda I
    Biochim Biophys Acta; 1994 Feb; 1225(3):317-25. PubMed ID: 8312380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired assembly of E1 decarboxylase of the branched-chain alpha-ketoacid dehydrogenase complex in type IA maple syrup urine disease.
    Wynn RM; Davie JR; Chuang JL; Cote CD; Chuang DT
    J Biol Chem; 1998 May; 273(21):13110-8. PubMed ID: 9582350
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular genetic characterization of maple syrup urine disease in European families.
    Peinemann F; Wendel U; Danner DJ
    Biochem Med Metab Biol; 1993 Dec; 50(3):338-45. PubMed ID: 8123297
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
    Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Yoshioka A; Matsuda I
    J Clin Invest; 1991 May; 87(5):1862-6. PubMed ID: 2022752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.
    Fisher CW; Fisher CR; Chuang JL; Lau KS; Chuang DT; Cox RP
    Am J Hum Genet; 1993 Feb; 52(2):414-24. PubMed ID: 8430702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular defects in the E1 alpha subunit of the branched-chain alpha-ketoacid dehydrogenase complex that cause maple syrup urine disease.
    Zhang B; Zhao Y; Harris RA; Crabb DW
    Mol Biol Med; 1991 Feb; 8(1):39-47. PubMed ID: 1943689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stable correction of maple syrup urine disease in cells from a Mennonite patient by retroviral-mediated gene transfer.
    Koyata H; Cox RP; Chuang DT
    Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):635-9. PubMed ID: 8240269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.